TY - JOUR
T1 - Increased inter dimeric interaction of oxy hemoglobin is necessary for attenuation of redutive pegylation promoted dissociation of tetramer
AU - Hu, Tao
AU - Li, Dongxia
AU - Meng, Fantao
AU - Prabhakaran, Muthuchidambaram
AU - Acharya, Seetharama A.
PY - 2011/4/1
Y1 - 2011/4/1
N2 - The propensity of site-specific carboxymethylation and Propylation of Val-1(α) of Hb to attenuate the reductive hexaPEGylation-induced dissociation of tetramers has been investigated. Only reductive Propylation of Val-1(α), which increases the stability of oxy Hb, attenuates the reductive hexaPEGylation-induced dissociation. Increasing the stability of the oxy conformation of Hb by chemical or genetic approaches is a strategy to generate PEGylated Hbs with native-like tetramer stability using direct PEGylation platforms. This new approach and EAF-PEGylation are the only two alternate PEGylation strategies available to design stable second-generation vasoinactive uncrosslinked PEGylated Hbs with native-like tetramer stability.
AB - The propensity of site-specific carboxymethylation and Propylation of Val-1(α) of Hb to attenuate the reductive hexaPEGylation-induced dissociation of tetramers has been investigated. Only reductive Propylation of Val-1(α), which increases the stability of oxy Hb, attenuates the reductive hexaPEGylation-induced dissociation. Increasing the stability of the oxy conformation of Hb by chemical or genetic approaches is a strategy to generate PEGylated Hbs with native-like tetramer stability using direct PEGylation platforms. This new approach and EAF-PEGylation are the only two alternate PEGylation strategies available to design stable second-generation vasoinactive uncrosslinked PEGylated Hbs with native-like tetramer stability.
UR - http://www.scopus.com/inward/record.url?scp=79952396185&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952396185&partnerID=8YFLogxK
U2 - 10.3109/10731199.2010.501756
DO - 10.3109/10731199.2010.501756
M3 - Article
C2 - 20653337
AN - SCOPUS:79952396185
SN - 2169-1401
VL - 39
SP - 69
EP - 78
JO - Biomaterials, Artificial Cells, and Immobilization Biotechnology
JF - Biomaterials, Artificial Cells, and Immobilization Biotechnology
IS - 2
ER -